Home Dermatology PDF: Bimekizumab for Moderate-to-Severe Plaque Psoriasis
- You cannot add another "PDF: Update on Drugs & Devices: September – October 2019" to your cart. View cart
$1.99
PDF Download: Bimekizumab is a novel treatment for moderate-to-severe plaque psoriasis that has shown promising efficacy and safety in clinical trials.
Article
Article
Article
Article